SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-025167
Filing Date
2024-03-22
Accepted
2024-03-22 16:25:39
Documents
19
Period of Report
2024-03-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0202366-8k_tffpharma.htm   iXBRL 8-K 48770
2 FORM OF COMMON WARRANT ea020236601ex4-1_tff.htm EX-4.1 93074
3 FORM OF WAINWRIGHT WARRANT ea020236601ex4-2_tff.htm EX-4.2 92989
4 OPINION OF GREENBERG TRAURIG, LLP ea020236601ex5-1_tff.htm EX-5.1 6874
5 FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF MARCH 20, 2024 ea020236601ex10-1_tff.htm EX-10.1 237971
6 PRESS RELEASE, DATED MARCH 20, 2024 ea020236601ex99-1_tff.htm EX-99.1 8861
7 PRESS RELEASE, DATED MARCH 22, 2024 ea020236601ex99-2_tff.htm EX-99.2 8664
  Complete submission text file 0001213900-24-025167.txt   796991

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE tffp-20240320.xsd EX-101.SCH 3018
9 XBRL LABEL FILE tffp-20240320_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE tffp-20240320_pre.xml EX-101.PRE 22361
22 EXTRACTED XBRL INSTANCE DOCUMENT ea0202366-8k_tffpharma_htm.xml XML 3715
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39102 | Film No.: 24775602
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)